These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4850070)

  • 21. [Interaction of vincamine on various effects of amphetamine at the central level].
    Sardi B; Pesce E; Piacenza G
    Farmaco Prat; 1978 Aug; 33(8):351-7. PubMed ID: 748060
    [No Abstract]   [Full Text] [Related]  

  • 22. Cerebral metabolic, hemodynamic and antihypoxic properties of l-eburnamonine.
    Linée P; Lacroix P; Le Polles JB; Aurousseau M; Boulu R; Van den Driessche J; Albert O
    Eur Neurol; 1978; 17 Suppl 1():113-20. PubMed ID: 753626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the activity of vindeburnol by spectral analysis of human EEG].
    Patat A; Klein MJ
    Therapie; 1986; 41(4):305-10. PubMed ID: 3554597
    [No Abstract]   [Full Text] [Related]  

  • 24. [Vincamine in the therapy of cerebral vascular diseases in the aged].
    De Candia O; Bartolucci E; Mancinella A; Baghiris D
    Clin Ter; 1979 May; 89(4):373-80. PubMed ID: 535317
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmaco-EEG study on vincamine and on teproside in patients with chronic cerebrovascular disease.
    Martucci N; Manna V; Agnoli A
    Int J Clin Pharmacol Res; 1984; 4(4):291-302. PubMed ID: 6500776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute i.v. vincamine teprosilate administration: quantified investigation in elderly subjects.
    Moglia A; Alfonsi E; Zandrini C; Pistarini C; Arrigo A
    Int J Clin Pharmacol Res; 1984; 4(4):303-6. PubMed ID: 6500777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of TCV-3B tablets on the thyroid function in patients with cerebrovascular disorders.
    Marimoto Y; Hanasaki N
    Ther Hung; 1985; 33(1):35-40. PubMed ID: 3841998
    [No Abstract]   [Full Text] [Related]  

  • 28. Cerebral antioedematous effect of Teproside and of some vincamine derivatives.
    Borzeix MG; Cahn J
    Int J Clin Pharmacol Res; 1984; 4(4):259-61. PubMed ID: 6500773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of vinpocetine on cerebral circulation in rats after exposure to radiation].
    Vereshchagin VK
    Eksp Klin Farmakol; 2003; 66(5):14-6. PubMed ID: 14650207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hemodynamic and metabolic technic of study of a drug with cerebrovascular action].
    Espagno J; Lazorthes Y; Arbus L
    Therapeutique; 1969 Nov; 45(9):888-90. PubMed ID: 5365416
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of vincamine on some enzymatic activities from various areas of the beagle dog cerebral cortex.
    Benzi G; Arrigoni E; Pastoris O; Marzatico F; Curti D; Piacenza G; Villa RF
    Farmaco Sci; 1981 Sep; 36(9):811-6. PubMed ID: 7297673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of Cetal retard in cerebral insufficiency in general practice].
    Bartels H
    Med Klin; 1979 Oct; Suppl():46-7. PubMed ID: 542167
    [No Abstract]   [Full Text] [Related]  

  • 33. [Multi-center study of Cetal retard. Results of 60 studies].
    Jeske H; Lehrl S; Rudschies H; Schulte-Steinberg G
    ZFA (Stuttgart); 1982 Mar; 58(7):430-8. PubMed ID: 7090516
    [No Abstract]   [Full Text] [Related]  

  • 34. [(U-14C) glucose metabolism in the brain in cerebrovascular disorders of the cat using the cerebral perfusion method].
    Otsuki S; Watanabe S; Mitsunobu K; Edamatsu K; Ninomiya K
    Igaku To Seibutsugaku; 1968 Aug; 77(2):43-9. PubMed ID: 5750574
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cerebral glucose metabolism in craniocerebral trauma: an evaluation].
    Schelp AO; Burini RC
    Arq Neuropsiquiatr; 1995 Sep; 53(3-B):698-705. PubMed ID: 8585834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro dissolution test: evaluation criterion for prolonged release dosage forms vincamine example (author's transl)].
    Buri P; Doelker E; Boucherat J
    Schweiz Rundsch Med Prax; 1981 Jul; 70(29):1310-3. PubMed ID: 7279852
    [No Abstract]   [Full Text] [Related]  

  • 37. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
    Periti P; Periti G; Colombo Pirola L
    Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
    [No Abstract]   [Full Text] [Related]  

  • 38. [Correlation of brain perfusion and brain metabolism with atrophic processes determined through pneumoencephalography].
    Hoyer S; Oesterreich K
    Nervenarzt; 1969 Dec; 40(12):561-5. PubMed ID: 5368416
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative study of 2 drugs used in the treatment of cerebral vascular insufficiency: I-Eburnamonine and Vincamine].
    Linquette M
    Lille Med; 1978 May; 23(5 Suppl 1):379-81. PubMed ID: 682847
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes in cerebral electrogenesis caused by vincamine in the baboon, Papio papio].
    Arfel G; de Pommery J; de Pommery H; de Lavarde M
    Rev Electroencephalogr Neurophysiol Clin; 1974; 4(1):53-67. PubMed ID: 4219639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.